Navigation Links
Loopholes in Federally Mandated IVF Reporting Lead Some Clinics to Artificially Inflate IVF Pregnancy Rates, Center for Human Reproduction Study Reports
Date:6/14/2013

New York, NY (PRWEB) June 14, 2013

A small number of IVF centers manipulate federally mandated reporting of IVF outcomes by artificially inflating their clinics’ IVF pregnancy rates, thus gaining economic advantages over properly reporting centers, a new study reports in Fertility & Sterility, the official medical journal of the American Society for Reproductive Medicine (ASRM).[1]

Under the Fertility Clinic Success Rate and Certification Act of Congress (FCSRCA) of 1992, IVF centers are required to report IVF cycle outcomes annually to the Centers for Disease Control and Prevention (CDC). Many centers report their outcome data to CDC through reports to the Society for Assisted Reproductive Technologies (SART), a daughter society of the ASRM, which maintains a voluntary national reporting system in parallel. Both outcome data sets are publicly available, and, despite representations from CDC and SART that comparisons between clinics based on these data can be misleading, patients often rely on these outcome data when selecting IVF centers.

The study, published by investigators from New York’s Center for Human Reproduction, evaluated the integrity of the national reporting system by focusing on how many IVF cycles individual clinics excluded from formal reporting. Using standard statistical methods to define outliers, the study found that only 13 out of 341 clinics (3.7%) represented 50% of all non-reported cycles. These 13 clinics failed to report outcomes for 37.3% of IVF cycles started at their centers. Further analysis demonstrated that a majority of non-reported cycles involved older women, who are expected to have lower pregnancy chances. The 13 clinics reported significantly higher pregnancy rates than all other clinics, and over the 5-year study period between 2005 and 2010 increased their share of the U.S. IVF market by as much as 19%.

“In essence, we found that 13 out of 341 analyzed IVF centers artificially inflated their pregnancy rates and, likely as a consequence, expanded their market share,” explains the study’s lead author, Vitaly A. Kushnir, MD, attending physician and assistant scientist at the Center for Human Reproduction (CHR), New York. Dr. Kushnir also serves as consultant to the CDC’s Reproductive Health Division, which publishes the Annual Clinic Reports, mandated by Congress.

“We conceived of this study because Senator Wyden, who was instrumental as Congressman in passage of the FCSRCA, recently suggested this national IVF reporting to CDC as a ‘good example’ for other reporting systems that could be implemented throughout medicine under the Affordable Care Act,” adds Norbert Gleicher, MD, the study’s senior author and Medical Director and Chief Scientist at CHR. Dr. Gleicher continues: “Our results, of course, suggest otherwise.”

[1]Kushnir VA, Vidali A, Barad DH, Gleicher N. The status of public reporting of clinical outcomes in assisted reproductive technology. Fertil Steril 2013 [Epub ahead of print].

About the Center for Human Reproduction (CHR)
The Center for Human Reproduction (CHR - http://www.centerforhumanreprod.com/), located in New York City, is one of the world’s leading clinical fertility and research centers. Drs. Kushnir and Gleicher are available for further comments.

Read the full story at http://www.prweb.com/releases/IVFpregnancyrates/newstudy/prweb10833316.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Federally funded clinics for low-income patients as effective as private practices
2. ACP and NACHC collaborate to help federally-qualified heath centers improve care
3. Federally funded research & development centers employed more than 3,000 postdoctoral researchers
4. AFTS Labs Partners With Physicians To Complement NY's Mandated I-STOP Tracking System For Pain Pill Prescriptions: A Recipe For A Safer Community
5. The REMARK checklist explained: How to use guidelines on reporting tumor marker prognostic studies
6. Reporting of hospital infection rates and burden of C. difficile
7. First validated method for analyzing flavanols and procyanidins in cocoa products could help scientists and the industry in standardized reporting
8. Penn researchers find error reporting improves perceptions of safety and may reduce incidents
9. UK initiates first cancer reporting model of its kind in US
10. EzCheckPrinting Updated with New Category Feature to Simplify Check Printing and Tax Reporting
11. EzW2 Software From Halfpricesoft.com Updated To Accelerate Tax Reporting For Startups
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... May 27, 2016 , ... Two director-level employees of Horizon Blue ... Women and Industry (TWIN) 2016 honorees. The award recognizes businesswomen who excel in ... Geri Boone, Director of the MLTSS (Managed Long-Term Services and Supports) Program at Horizon ...
(Date:5/27/2016)... ... 27, 2016 , ... This campaign aims to provide a path to improved ... can control and change. , As nearly 795,000 Americans suffering from a new or ... States. Plus, with an estimated 129,000 of these people dying from stroke, it’s become ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees ... stories, courtesy of leaders in the nursing and health care industry. It also ... advocates and associations—namely Jones & Bartlett Learning. , Jones & Bartlett Learning is ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media ... Janet Yellen and company to wait until March 2017 for an interest rate increase, ... Mack Robinson College of Business. , “The Federal Open Market Committee (FOMC) dot charts ...
(Date:5/26/2016)... Missouri (PRWEB) , ... May 26, 2016 , ... ... quality and clinical outcomes, hosted members and suppliers for its inaugural Member Conference ... focus on their mission of elevating the operational health of America’s healthcare providers. ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... Germany and GERMANTOWN, Maryland ... (NASDAQ: QGEN ; Frankfurt Prime Standard: QIA) today ... co-development agreement with Therawis Diagnostics GmbH to develop and commercialize ... develop and market PITX2 as a marker to predict effectiveness ... cancer patients. "We are pleased to partner with ...
(Date:5/25/2016)... 2016 As illustrated by the ... month, the numbers and momentum of cannabis in the ... the billions, more research and development push the sector ... of Legal Marijuana Markets Report  from from ArcView Market ... of the increase in sector is attributed to adult ...
(Date:5/25/2016)... , May 25, 2016 ... the precision of circulating tumour DNA (ctDNA) analysis ... the appointment of Professor Clive Morris ... leadership across the clinical development programme, scientific collaborations, ... help deliver significant improvements in clinical outcomes for ...
Breaking Medicine Technology: